Metraipolis › archive › dc_7ca67c70eb94

Tirzepatide and metabolic dysfunction-associated steatotic liver disease (MASLD) in obesity: a real-world multicenter study — Europe PMC PMID:42518535

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42518535
DOI
10.3389/fendo.2026.1855886
License (as archived)
solo-consultazione
Archived
2026-10-08T14:29:06.465Z
SHA-256 of the archived text
d1cfe88cb1cb14d04e75b9e3987de86375211a239e01fdfcbf0f091b8f4e11d7
Stable URL of this page
https://metraipolis.com/documento/dc_7ca67c70eb94

How to cite

Tirzepatide and metabolic dysfunction-associated steatotic liver disease (MASLD) in obesity: a real-world multicenter study — Europe PMC PMID:42518535 — Europe PMC (en), https://europepmc.org/article/MED/42518535 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7ca67c70eb94 (Metraipolis archive dc_7ca67c70eb94, sha256 d1cfe88cb1cb14d04e75b9e3987de86375211a239e01fdfcbf0f091b8f4e11d7)
BibTeX
@misc{dc7ca67c70eb94,
  title = {Tirzepatide and metabolic dysfunction-associated steatotic liver disease (MASLD) in obesity: a real-world multicenter study — Europe PMC PMID:42518535},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42518535},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7ca67c70eb94; sha256 d1cfe88cb1cb14d04e75b9e3987de86375211a239e01fdfcbf0f091b8f4e11d7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42518535. Agents can read the archived copy with the MCP tool read_document.